University of Waterloo News
Akseera’s research partner, Prof. Robin Duncan discusses her findings on Synthetic CBD and its effects in preventing COVID-19. The key finding of Robin’s research [...]
Akseera’s research partner features on Canada’s Prime Time News
Akseera’s research partner at University of Waterloo; Prof. Robin Duncan features on Prime Time news with David Cochrane at CBC. Robin presents her findings [...]
Akseera’s study features in Ontario University’s Top Stories
Prof. Robin Duncan; Akseera’s research partner at University of Waterloo was recently featured on Global news discussing her findings on Synthetic CBD and its [...]
Akseera’s research on the effects of CBD on SARS-CoV-2 genes noted in Bio-archives
Akseera Research noted in BioRxiv.org A pre-peer-reviewed version of the study ‘Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to [...]
Akseera featured in Moneycontrol.com
Akseera Pharma was featured in Moneycontrol.com - "This Canadian startup plans to repurpose Cannabis-derived drug for cardiac diseases linked to COVID-19" - Here is [...]
Akseera Research Noted In British Journal of Pharmacology
Our research at Simon Fraser University has met a major milestone of identifying the effect of Cannabinoids on Cardiac Cells specifically related to [...]
Trade Commissioners of Canada in India
As a Canadian Corp., we are supported by the Trade Commissioners of Canada in India to develop and launch our products. Akseera was [...]
CEO Manit Patel invited to Cannabiz Invest Asia (2019)
Our CEO Manit Patel was invited to present at the Cannabiz Invest Asia (2019) on Biosynthesis of Cannabinoids. This presentation received much interest from investors, governments (Singapore and [...]